June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Oral Administration of Picrorrhizae Extract Ameliorates Retina Damage in Rat Optic Nerve Crush Model
Author Affiliations & Notes
  • Yang Qu
    Opthalmology, Shenyang 4th People's Hospital, Shenyang Eye Research Institute, Shenyang, China
  • Shaodan Zhang
    Opthalmology, Shenyang 4th People's Hospital, Shenyang Eye Research Institute, Shenyang, China
  • Ruoxi Li
    Opthalmology, Shenyang 4th People's Hospital, Shenyang Eye Research Institute, Shenyang, China
  • Footnotes
    Commercial Relationships Yang Qu, None; Shaodan Zhang, None; Ruoxi Li, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3265. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yang Qu, Shaodan Zhang, Ruoxi Li; Oral Administration of Picrorrhizae Extract Ameliorates Retina Damage in Rat Optic Nerve Crush Model. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3265.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the neuronal protective effect and therapeutic mechanisms of Picrorrhizae extract (PRE) in rat optic nerve crush model.

Methods: Wistar male rats (250-300 g, China Medical University, Shenyang) were anesthetized with intraperitoneal injection of chloral hydrate (25-30 mg/100g, Sinopharm). Optic nerve was crushed 2mm behind the right eye with angled forceps for 5 sec. After the model was established, PRE (Log No.1202113, Tianjiang Pharmaceutical, Jiangsu) at the dosages of 10mg/100g, 50mg/100g and 100mg/100g was intragastrical given to the rats at eight time points (day 0, 1, 3, 5, 7, 14, 21, 28). Distilled water was intragastrically given to the control rats with (crush group) and without (normal group) crush. In vivo retina thicknesses were measured using OCT (ZEISS Cirrus™ HD-OCT 4000) at day 29, cryosections were then made from enucleated eye and retinal histological structures were observed under light microscope (Leika DM1000).

Results: In normal rats, oral administration of PRE at 50mg/100g and 100mg/100g apparently broke down the normal histological structures of retina, suggesting the toxic effect on the neuronal tissues at these dosages. The retina structure remained intact when 10mg/100g PRE was administrated, at which dosage the therapeutic effect of PRE on optic nerve crush was tested (10mg PRE group). Using OCT, the retinal thickness measured 500μm away from optic papilla was significantly reduced in the crush group (129.98±17.15μm, n=5) compared to that in the normal group (198.50±7.78μm, n=3, p<0.05). Whereas in 10mg PRE group, the retinal thickness was 173.78±14.92μm (n=5), with no statistical difference from that in the normal group (p>0.05). In retina HE cryosections, the counts of retinal ganglion cells, retina thickness normalized by the thickness of outer nuclear layer and thickness of retinal fiber layer were measured. In 10mg PRE group, the values were 38.8±2.17, 3.13±0.14 and 89.6±2.70μm, respectively (n=5), significantly larger than those in the crush group, which were 10.25±1.71, 2.0±0.16 and 40±2.16μm, respectively (n=4, p<0.05). The data did not show statistical difference from those in the normal group, which were 47±1.63, 3.2±0.05 and 110.2±1.71μm, respectively (n=4, p>0.05).

Conclusions: Oral administration of PRE restores retina structure as observed in OCT and histological study, suggesting a therapeutic effect of PRE on optic neuropathy.

Keywords: 615 neuroprotection • 503 drug toxicity/drug effects • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×